Clinical Edge Journal Scan

Exposure to antibiotics in early life not linked to atopic dermatitis onset in childhood or adolescence


 

Key clinical point: Exposure to antibiotics in early life was not associated with an increased risk of development of atopic dermatitis (AD) from 1 year of life up to adolescence.

Major finding: Antibiotic exposure vs no exposure during the first 6 months of life (adjusted hazard ratio [aHR] 1.05; 95% CI 0.97-1.12), first year of life (aHR 1.02; 95% CI 0.97-1.07), and first 2 years of life (aHR 1.01; 95% CI 0.94-1.10) was not associated with an increased risk of development of AD.

Study details: Findings are from a retrospective study including 73,816 children aged 0-14 years, of which 34,202 were exposed to antibiotics.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Cantarutti A et al. Early-life exposure to antibiotics and subsequent development of atopic dermatitis. Expert Rev Clin Pharmacol. 2022 (Jun 20). Doi: 10.1080/17512433.2022.2092471

Recommended Reading

‘I shall harm’
MDedge Dermatology
Multi-dimensional and heterogeneous nature of disease burden in atopic dermatitis
MDedge Dermatology
Adolescents and children with moderate-to-severe atopic dermatitis benefit from dupilumab
MDedge Dermatology
Moderate-to-severe atopic dermatitis: Abrocitinib improves clinical scores in IGA nonresponders
MDedge Dermatology
Atopic dermatitis: Improvement in disease severity and skin barrier function with dupilumab
MDedge Dermatology
Atopic dermatitis: Upadacitinib-induced acne does not pose a significant safety risk
MDedge Dermatology
Difamilast shows promise as long-term therapeutic option for atopic dermatitis
MDedge Dermatology
Identifying factors associated with AD severity
MDedge Dermatology
Pediatric atopic dermatitis: Food allergy common but AD rarely triggered by food
MDedge Dermatology
Pediatric atopic dermatitis: Food allergy common but AD rarely triggered by food
MDedge Dermatology